Remote Jobs at Instylla

Instylla

11 - 50 employees

Founded 2017

🧬 Biotechnology

🤝 B2B

🔥 Funding within the last year

💰 $21.7M Series C - Instylla on 2025-10

Biotechnology • B2B

Instylla is a privately held MedTech company based in Bedford, MA focused on developing novel resorbable embolic agents to advance interventional radiology, with initial clinical applications in interventional oncology. Its lead products include the Embrace™ Hydrogel Embolic System, the first liquid embolic approved for hypervascular tumor embolization supported by a prospective randomized clinical trial and FDA premarket approval, and the Tembo™ Embolic System, a resorbable gelatin particle embolic for peripheral vascular occlusion. Instylla conducts clinical studies, supports commercial launch and works with interventional radiologists to provide targeted, resorbable embolization therapies that occlude tumor blood flow while leaving options open for future treatments.